Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Université du Québec à Montréal

$25,000.00

Development of a concise synthesis of analogs derived from Amaryllidaceae alkaloids family******************

EF 2018-19

Résumé
This present proposal focuses on a close collaboration between UQAM and IntelliSyn pharma to valorize and produce analogs that have been obtained during a fundamental project aiming the total synthesis of highly bioactive small natural products. The main objective is to develop a concise and efficient synthetic pathway to produce analogs derived from Amaryllidaceae family, an important class of bioactive alkaloids. Natural products from this family such as lycoricidine, narciclasine, pancrastistatin and their natural derivatives are known for their important bioactivity against several cancers. These compounds have the advantage to be small bioactive molecules that can be obtained in large scale by total synthesis, which is not the case with complex drugs such as taxol or vinblastine. A new approach of these alkaloids has been developed; this method allows producing in few steps their main cores containing the crucial bioactive moieties. This new synthetic approach generates analogs that were not yet produced by known synthetic pathways and could open-up novel opportunities. Collaboration with a recognized company such as IntelliSyn pharma will help us to produce interesting scaffolds with required physico-chemical properties.*
Programme
Engage Grants Program
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
535879-2018
Name nom
Canesi, Sylvain
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Development of a concise synthesis of analogs derived from Amaryllidaceae alkaloids family******************
Keyword
NSERC
Application summary
This present proposal focuses on a close collaboration between UQAM and IntelliSyn pharma to valorize and produce analogs that have been obtained during a fundamental project aiming the total synthesis of highly bioactive small natural products. The main objective is to develop a concise and efficient synthetic pathway to produce analogs derived from Amaryllidaceae family, an important class of bioactive alkaloids. Natural products from this family such as lycoricidine, narciclasine, pancrastistatin and their natural derivatives are known for their important bioactivity against several cancers. These compounds have the advantage to be small bioactive molecules that can be obtained in large scale by total synthesis, which is not the case with complex drugs such as taxol or vinblastine. A new approach of these alkaloids has been developed; this method allows producing in few steps their main cores containing the crucial bioactive moieties. This new synthetic approach generates analogs that were not yet produced by known synthetic pathways and could open-up novel opportunities. Collaboration with a recognized company such as IntelliSyn pharma will help us to produce interesting scaffolds with required physico-chemical properties.*